Call Options

15 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$221.47 - $242.41 $2.92 Million - $3.2 Million
-13,200 Reduced 81.99%
2,900 $699,000
Q2 2024

Aug 14, 2024

SELL
$225.07 - $246.17 $2.39 Million - $2.61 Million
-10,611 Reduced 39.73%
16,100 $3.76 Million
Q1 2024

May 15, 2024

BUY
$233.45 - $247.73 $1.92 Million - $2.03 Million
8,211 Added 44.38%
26,711 $6.61 Million
Q4 2023

Feb 14, 2024

BUY
$232.24 - $267.23 $4.3 Million - $4.94 Million
18,500 New
18,500 $4.51 Million
Q2 2023

Aug 14, 2023

BUY
$238.39 - $265.32 $595,975 - $663,300
2,500 New
2,500 $660,000
Q1 2022

May 16, 2022

SELL
$243.64 - $270.48 $194,912 - $216,384
-800 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$230.08 - $250.94 $184,064 - $200,752
800 New
800 $201,000
Q3 2021

Nov 15, 2021

SELL
$232.72 - $256.47 $10.6 Million - $11.6 Million
-45,400 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$232.65 - $254.58 $5.44 Million - $5.96 Million
23,400 Added 106.36%
45,400 $11 Million
Q1 2021

May 17, 2021

BUY
$232.09 - $256.88 $2.18 Million - $2.41 Million
9,400 Added 74.6%
22,000 $5.35 Million
Q4 2020

Feb 16, 2021

BUY
$221.92 - $245.94 $2.8 Million - $3.1 Million
12,600 New
12,600 $3.15 Million
Q4 2018

Feb 14, 2019

SELL
$204.73 - $257.93 $6.47 Million - $8.15 Million
-31,600 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$233.07 - $256.0 $1.19 Million - $1.31 Million
5,100 Added 19.25%
31,600 $8.25 Million
Q2 2018

Aug 14, 2018

BUY
$208.1 - $233.85 $4.66 Million - $5.24 Million
22,400 Added 546.34%
26,500 $6.35 Million
Q3 2017

Nov 14, 2017

BUY
$186.89 - $198.9 $766,249 - $815,490
4,100
4,100 $803,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.2B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.